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The European Prospective Investigation of Cancer (EPIC) is a 10-
country collaborative study in which EPIC-Norfolk is one of the UK
centres. EPIC-Norfolk examined 25 639 men and women resident in
East Anglia (aged 40–79 years), between 1993 and 1997. The EPIC
collaboration was set up to examine the dietary determinants of
cancer, but the remit in the EPIC-Norfolk cohort was broadened
from the outset to include determinants of other health conditions
and chronic diseases. EPIC-Norfolk completed a third round of
health examinations (EPIC-Norfolk 3 or 3HC) in December 2011,
on 8623 participants in the age range 48–92 years. EPIC-Norfolk
focused on objective measures of cognitive function, physical cap-
ability and visual health, adapting this existing mid-life cohort to
the current need to investigate healthy and independent living for
ageing societies. With a wealth of longitudinal data and a biobank
(including DNA) collected at up to three separate time points,
EPIC-Norfolk offers the unique opportunity to investigate the asso-
ciation of lifestyle and biological factors, including genetic expos-
ures, with a range of health outcomes in middle and later life.
Information for data access can be found on the study website,
details as given in this cohort profile.
Background
The numbers of older people worldwide are increasing
at an unprecedented rate and good health and well-
being in later life are now major priorities.1 To main-
tain good health in later life, we need to improve our
understanding of how to influence conditions such as
dementia, sarcopenia, age-related macular degener-
ation and glaucoma. These conditions are more preva-
lent in older age but are not necessarily an inevitable
consequence of ageing, with substantial variations
seen in the health and functional status of older
people. Understanding determinants of these
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conditions may help us understand how best to post-
pone or reduce disability and disease in later life.
The occurrence of chronic disease, disability and de-
pendence increases with age. With more people living
longer, this is a challenge to society with considerable
cost implications for our health services.2 Ageing is
often characterized by a complex combination of mor-
bidities, and we need to consider not just disease pre-
vention but also slowing down the progression to
disability. Delaying onset of disease and improving
survival (e.g. through effective control of vascular
risk factors) can reduce the numbers of individuals
with disability in later life.3 A small change in the
incidence of common conditions may have a profound
impact on projections of future numbers with disabil-
ity in the population.3–6 Through EPIC-Norfolk, we
aim to get a better understanding of the causes of
disease and the reasons for health inequalities so as
to eventually inform policies for health improvement
and disease prevention in middle and later life.
Why was the EPIC-Norfolk cohort
set up and what was the rationale
for EPIC-Norfolk 3?
The European Prospective Investigation into Cancer
(EPIC) is an international collaboration studying
diet and disease, with half a million participants.7,8
EPIC-Norfolk is one of the UK centres of this 10-
country collaboration and, although part of the diet
and cancer study, its remit was widened soon after its
inception to include investigation of major determin-
ants of chronic disease, disability and death in middle
and later life. EPIC-Norfolk has had a particular focus
on characterizing exposures in terms of modifiable
lifestyle factors such as diet, physical activity and psy-
chosocial factors. Key priorities have been to develop
improved methods of exposure measurement and to
characterize participants extensively in terms of their
lifestyle, physiological, metabolic and genetic profiles.
A wealth of prospective data on health and lifestyle
exposures including objective measures has now been
collected over almost 20 years of follow-up.
The baseline health examination (1HC 1993–97)
focused on obtaining detailed information on lifestyle
(including diet and physical activity), medical history
and measurements of cardiovascular disease risk fac-
tors including anthropometry and blood pressure.
Characteristics of the cohort at baseline have been
described previously.9 A second health examination
(2HC 1997–2000) repeated measures collected at
baseline, with the addition of heel bone ultrasound10
and impedance for body fat percentage.
The main focus of the third health examination,
EPIC-Norfolk 3 (3HC 2006–11) was to investigate
conditions relevant to ageing in participants now in
the age range of 48–92 years. Measures taken previ-
ously were repeated to document longitudinal
trajectories in behaviours, physiological characteristics
and health status. EPIC-Norfolk 3 is centred mainly
on three areas associated with major causes of loss of
independence and increasing disabilities in later life:
cognitive decline, loss of mobility and loss of vision,
all which have been associated with the onset of
disability.11,12
Although memory impairment and cognitive decline
generally increase with age, there is a broad range of
cognitive capability within the older population.13
Decline in muscle mass and function with advanced
age (sarcopenia) is associated with considerable mor-
bidity and mortality amongst older persons, with sub-
stantial healthcare costs.14 Visual impairment is not
only a source of morbidity in itself, but also increases
the risk of future functional impairment, disability
and mortality.15 Certification figures for visual impair-
ment for England and Wales show that the three
leading causes for both blindness and partial sight
are age-related macular degeneration, glaucoma and
diabetic retinopathy.16 These eye conditions, along
with uncorrected refractive error which [according
to the World Health Organization (WHO)17] is glo-
bally the major cause of visual impairment, are the
main ophthalmic conditions investigated in EPIC-
Norfolk 3.
Procedures in this study were approved by the
Norfolk Local Research Ethics Committee (05/Q0101/
191) and East Norfolk and Waveney NHS Research
Governance Committee (2005EC07L). Participants
gave signed informed consent. As part of the research
process, the EPIC-Norfolk team actively promotes the
involvement of participants. A participants’ advisory
panel (EPAP: EPIC Participant Advisory Panel) ad-
vises on various aspects of the study and gives their
views on potential future projects.
Who is in EPIC-Norfolk 3 and how
often have they been followed up.
In total 77 630 individuals from 35 general practices
in Norfolk were invited at baseline to take part in this
prospective cohort study. Of these, 30 445 consented
to take part and completed a health questionnaire. It
is difficult to compare characteristics between re-
sponders and non-responders as limited data are
available on non-responders. Of those approached,
42% of all women agreed to take part as compared
to 36% of all men. Table 1 shows the distribution of
participants, where non-responders were likely to be
men and slightly younger. However, all ages were well
represented for both men and women in the cohort
including those in the 70þ age group. Also, as
described previously, the participating cohort was
similar to the national population samples studied
in the Health Survey of England, in terms of anthro-
pometry, serum lipids and blood pressure.9
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Figure 1 summarizes the numbers of participants
involved over the 19-year follow-up, and participation
at each stage. In addition to health examinations, par-
ticipants have been invited to complete health and
lifestyle questionnaires at regular intervals. The
number of participants who attended the 1HC was
25 639 (response rate of 33%). For subsequent
approaches, all those who consented at baseline
were invited to take part after excluding those who
had died and those who had previously requested no
further approaches. Record linkage to the NHS Exeter
System ensured participant contact information was
up to date. The number of participants attending the
2HC was 15 786 (a response rate of 57.6%), with the
remainder (3774 participants) completing the health
questionnaire only. The number of participants who
died before the point in time when they were due to
receive an invitation to 2HC was 1214. A further 1832
either refused or could not be contacted (i.e. address
not known). Using the same criteria from the 2HC
(inviting participants still alive, not having refused
further approaches and with a contact address),
18 380 participants were approached for EPIC-
Norfolk 3 (3HC) and the pilot phase. This included
7547 participants who did not attend the 2HC (but
79% of whom did attend the 1HC, the remaining 21%
not attending the health examination, but completing
a health and lifestyle questionnaire at baseline). There
were 5495 deaths recorded up to this point. Of those
invited to EPIC-Norfolk 3, 8623 (response rate of
46.9%) attended the health examination.
Participants were sent an invitation and a health
and lifestyle questionnaire (HLQ) for EPIC-Norfolk
3. Participants sent their responses on a participation
form indicating their preference of timings and re-
turning their completed HLQ, in a freepost envelope.
Every endeavour was made to facilitate participa-
tion (see Supplementary Appendix available as
Supplementary data at IJE online). Practices were
approached two at a time, based on geographical lo-
cation and distance from the clinic in Norwich, i.e.
one at close proximity (city practice) and one further
afield (rural area). Funding constraints led to the ex-
clusion of four practices from follow-up. As a result of
not including these practices, 1517 eligible partici-
pants were not approached. The follow-up period be-
tween 2HC and the most recent phase was up to 10
years (compared with follow-up between 1HC and
2HC, which was up to 5 years).
To examine attrition in the cohort, the baseline
characteristics of those who attended both the 1HC
and EPIC-Norfolk 3 (3HC) were then compared with
the 17 789 participants who attended the 1HC only
(Table 2). The proportions of men and women were
similar, with women comprising 55.3% of the group
attending both baseline and follow-up health exam-
inations and 54.5% of those attending the baseline
health examination only (P¼ 0.2).
Those who returned to take part in EPIC-Norfolk 3
were, at the time of the first health examination,
more likely to be younger and taller and have lower
weight, lower blood pressure and lower cholesterol
concentrations. They were also more likely to be edu-
cated to at least to O-level standard or equivalent (i.e.
leaving school with exams at 16 years of age), to have
a higher socioeconomic status, to havenever smoked
and to have been more physically active. Responders
to EPIC-Norfolk 3 were also more likely to drink more
alcohol at baseline than those who did not respond.
Table 2 shows that the trends seen in the baseline
characteristics were the same in both men and
women. Although, as might be expected, those attend-
ing EPIC-Norfolk 3 were younger, with a better cardio-
vascular disease risk profile and socioeconomic status at
baseline compared with those not attending, the cohort
still represents a diverse population with a wide socio-
economic distribution and range of lifestyle factors of
interest, such as physical activity and obesity.
What has been measured?
The 1HC and 2HC lasted approximately 30 min and
comprised anthropometry, simple physiological meas-
ures including respiratory function [FEV1 (forced ex-
piratory volume in 1 s)], blood pressure, venepuncture
for blood and urine sample collection. In contrast, the
Table 1 Age and sex of responders and non-responders at
baseline
Variable
Responders Non responders
39% (N¼ 30 445) 61% (N¼ 47 185)
Men 48.7% (37 825)
% (N) 36.2 (13 700) 63.8 (24 125)
Age group (years)
444 4.3 (587) 6.5 (1572)
45-49 16.7 (2287) 21.0 (5061)
50-54 15.9 (2178) 18.2 (4385)
55-59 15.2 (2075) 15.1 (3649)
60-64 15.6 (2142) 13.1 (3165)
65-69 15.4 (2112) 11.8 (2848)
570 16.9 (2319) 14.3 (3445)
Women 51.3% (39 805)
% (N) 42.1 (16 745) 57.9 (23 060)
Age group (years)
444 4.6 (778) 6.2 (1422)
45-49 18.4 (3084) 18.7 (4304)
50-54 16.1 (2699) 16.1 (3717)
55-59 15.1 (2523) 13.8 (3189)
60-64 14.8 (2482) 13.0 (3009)
65-69 14.9 (2492) 13.4 (3080)
570 years 16.1 (2687) 18.8 (4339)
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Figure 1 EPIC-Norfolk study over more than 18 years of follow up, showing numbers of participants who responded
positively and attended health examinations and those lost to follow up at each phase
*These 7547 participants consented to take part at baseline (of which 5970 attended 1HC), but did not attend 2HC, They are
included in the count for participants remaining in Study at the time of EPIC-Norfolk 3 approach
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EPIC-Norfolk 3 health examination took from 2 h
30 min to 3 h to complete, depending on the partici-
pant. Assessments were carried out using standar-
dized procedures by nurses, who received an initial
3-month intensive training with annual refresher
courses.
Participants taking part in EPIC-Norfolk 3 gave
signed informed consent again to cover the new
areas of data collection. A sample copy of the consent
form was sent in the invitation pack for information,
but consent was taken in the presence of the nurse
(see the Supplementary App for details, available as
Supplementary data at IJE online). Full lists of meas-
urements, including repeated measures, are detailed
in Boxes 1 and 2.
At the end of the health examination, participants
were given a feedback form (which was optional and
anonymized, unless the participant chose to give their
contact details) to gather information on the quality
of the experience of the health examination.
Participants were given feedback on some results
and clinically relevant results were sent to the general
practitioners (with the permission of participants)
with pre-agreed threshold levels for immediate notifi-
cation. The data from the eye examination were re-
viewed by an ophthalmologist and participants with
abnormal results were referred to a specialist clinic set
up at the Norfolk & Norwich University Hospitals
(NNUH) NHS Foundation Trust.
What has it found? Key findings
and publications
EPIC-Norfolk has published several hundred papers
using data collected prior to EPIC-Norfolk 3. These
can be found on our website (www.epic-norfolk.org.
uk). Included in our key findings are some high pro-
file papers such as those showing that the combined
impact of four health behaviours (not smoking,
Table 2 Baseline characteristics of participants in EPIC-Norfolk. Participants who attended health examinations in both
the first and third phases of EPIC-Norfolk (1HCþ 3HC) are compared with those who were examined in the first phase only
(1HC only)
Variable
Men Women
1HCþ 3HC 1HC only P-value 1HCþ 3HC 1HC only P-value
(N¼ 3615) (N¼ 7992) (N¼ 4495) (N¼ 9537)
Mean (SD)a
Age (years) 56.6 (7.9) 61.0 (9.5) <0.001 55.2 (7.8) 60.7 (9.5) <0.001
Height (cm) 174.9 (6.5) 173.6 (6.7) <0.001 162.1 (6.0) 160.4 (6.3) <0.001
Body mass index (kg/m2) 26.1 (3.0) 26.7 (3.4) <0.001 25.5 (4.1) 26.6 (4.4) <0.001
Systolic blood pressure (mmHg) 134.2 (16.3) 138.9 (18.1) <0.001 129.4 (17.1) 136.0 (19.4) <0.001
Total cholesterol (mmol/l) 6.0 (1.1) 6.1 (1.1) 0.007 6.1 (1.1) 6.4 (1.2) <0.001
Frequency, % (N)b
Education
No qualification 22.0 (795) 34.3 (2739) <0.001 29.5 (1327) 48.2 (4593) <0.001
O-level or equivalent (or above) 78.0 (2819) 65.7 (5245) <0.001 70.5 (3167) 51.8 (4936) <0.001
Social class (% I-IIINM) 65.0 (2333) 55.4 (4324) <0.001 67.5 (3001) 58.5 (5393) <0.001
Smoking
Current 8.7 (313) 13.8 (1092) 8.8 (392) 12.6 (1187)
Ex-smoker 49.7 (1792) 56.7 (4492) 30.3 (1354) 33.2 (3123)
Never 41.6 (1498) 29.5 (2339) <0.001 61.0 (2729) 54.2 (5108) <0.001
Physical activity
Inactive 23.1 (834) 34.4 (2752) 20.3 (914) 35.3 (3363)
Moderately-Inactive 26.1 (945) 24.0 (1913) 33.2 (1493) 31.5 (3000)
Moderately-active 25.0 (905) 22.0 (1755) 26.0 (1168) 20.4 (1948)
Active 25.8 (931) 19.7 (1571) <0.001 20.5 (920) 12.9 (1226) <0.001
Median (IQR)c
Alcohol intake (units/week) 7 (2.5, 14.5) 6 (2, 14) <0.001 2.5 (1, 7.5) 2 (0.5, 6) <0.001
Groups were compared using unpaired Student’s t-testa, chi squareb and Mann-Whitneyc tests as appropriate. 1HC, first health
examination; 3HC, third health examination (EPIC-Norfolk 3); SD, standard deviation; IQR, interquartile range; I-IIINM: social
class I-III Non-Manual.
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drinking between 1 and 14 units of alcohol, having
some daily physical activity and eating at least five
portions of fruit and vegetables every day) resulted
in lower cardiovascular and mortality rates.
Furthermore, those with all four behaviours each
day lived on average 14 years longer than people
who adopted none.18 This finding was used to
inform the Government’s Small Change, Big Difference
Campaign in 2006.
The data collection phase for EPIC-Norfolk 3 ended
in December 2011, and the data are currently being
cleaned and made available for further analysis. Five
papers (listed below) have been published using in-
terim data. A key finding is that although the cohort
is somewhat selected at this stage of the study, and
prevalence of severe impairment is relatively low in
our participants, there is considerable heterogeneity
in function and health in the EPIC-Norfolk 3 cohort
(Table 3), with some participants in the oldest age
group performing better or with better function and
health than those in the youngest group.
Validation of the short form mini-mental
state examination (SF-MMSE)19
The SF-MMSE is a shortened version of the widely
used Mini Mental State Exam (MMSE).20 We demon-
strated that the SF-MMSE captures the full range of
scorers from the severely impaired to the high func-
tioning and that the full-scale MMSE scores could be
accurately derived from this 11-item abbreviated ver-
sion. This is important within frameworks such as
epidemiological studies that require shorter testing
methods but need results that are comparable to stu-
dies where the full test version has been
administered.
Box 1 Self report data collected from questionnaires in EPIC-Norfolk 3 (details on these measures can be found in
Supplementary Data)
Health and Lifestyle Questionnaire (Follow-Up IV)
Socio-demographic
Employment status
Self-rated health and diagnosis (including vision and hearing)
Social networks and support, leisure activities and hobbies
Activities of daily living
Falls
Medication
Smoking and alcohola (Alcohol intake measure of unit per week was calculated from number of drinks consumed per
day over 7 days, which was different from baseline which was calculated from total number of drinks consumed over
7 days).
Self-perceived wealth and economic statusa
Health and Life Experiences Questionnaire (HLEQ)
Psychosocial measures
Widespread pain using the Manchester Coding Systema
Social life
Loneliness
Anxiety and depression
Mood status
Health
Daily activities, lifetime events
Childhood experiences, personal beliefs
Physical Activity Questionnaire (EPAQ2) and perception of local environment
Self-report on physical activity behaviours in three domains: activity at home, work and recreation. Also, using
Geographical Information Systems (GIS)a with Neighbourhood Environment Walkability Scale (NEWS) to observe
how environmental factors play a role in determining behaviour
Skin ageing
Self-report on exposure to UV sunlight (lifetime and previous year)
Skin reaction to sunlight exposure
Tanning (including attitude towards UV exposure)
Use of sun protection/skin care
Natural hair colour (at age 20 years and current)
Dietary data
7-day food diary and Food Frequency Questionnaire (FFQ)
aNew measures in EPIC-Norfolk 3 (not applied at previous phases).
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Physical activity and ocular perfusion
pressure (OPP)21
OPP is the difference between arterial blood pressure
(BP) and intraocular pressure (IOP), and low OPP has
been implicated as a risk factor for open-angle glau-
coma (OAG). Using eye data from EPIC-Norfolk 3 and
physical activity data from an earlier phase has shown
that individuals with a previous active lifestyle have a
lower risk of a low OPP. Although further investiga-
tions are needed, these results show that physical
activity may be a safe and simple way of reducing
the risk of developing OAG.
Refractive error (RE), axial length and
anterior chamber depth of the eye22
Axial length of the eye is associated with RE, a major
cause of visual impairment and disability in the UK,
as well as a risk for glaucoma. Findings from EPIC-
Norfolk 3 have added support to previous work which
Box 2 New and repeat objective measures applied at clinic
Venous blood sample Biomarkers included full blood count (platelets, total white blood count,
neutrophils, basophils, eosinophils, monocytes, lymphocytes, total red
blood cell count), mean corpuscular volume, hamatocrit, haemoglobin;
glycated haemoglobin; lipid profile (total cholesterol, HDL LDL, trigly-
ceride); vitamin C; creatinine; albumin; and C-reactive protein. Serum,
plasma and whole blood also stored for future biochemical profiling and
DNA extraction
Anthropometric measures Standing height (Stadiometer, Chasmores, UK), weight, waist and hip
circumference
Impedance/body fat Body fat percentage measured using TANITA TBF-300 MA Body
Composition Analyser (Tanita UK, Yiewsley, UK)
Physiological functions Brachial pressure and heart rate measured with Accutorr PlusTM automatic
sphygmomanometer blood pressure monitor (Datascope Medical,
Huntingdon, UK). Also measured was Ankle Brachial Pressuresausing
the mini Dopplex D990 Doppler Pen with ultrasonic Doppler flow de-
tector (Huntleigh Healthcare, UK) and respiratory function using a
portable spirometer (Micro Medical, UK).
Ultrasound measurements of the calcaneus Attenuation of broadband ultrasound(dB/MHz) and speed of sound (m/s)
were measured three times on each foot with CUBA clinical instrument
(McCue Ultrasonics, Winchester, UK)
Skin ageinga Digital Images of skin on face and hands taken and stored for future
grading
Cognitive assessmena Retrospective and prospective memory, attention and calculation, registra-
tion, new learning, language, executive function, proxy measure of IQ
and visuospatial /constructional ability
Physical capabilitya Usual walking speed, standing balance, chair stands, grip strength using a
Smedley’s Dynamometer (Scandidact, Kvistgaard, Denmark)
Objective measure of physical activitya Physical activity using a commercial accelerometer, the GT1M (Actigraph,
Florida, USA)
Eye examinationa Visual acuity using the LogMAR visual acuity chart 1 (Precision Vision,
LaSalle, IL, USA), intraocular pressure using an AT555 Non-Contact
Tonometer (Reichert, New York, USA) and later using the Ocular
Response Analyzer (ORA, Reichert, New York, USA), axial length and
anterior chamber depth using IOLMaster, (Carl Zeiss Meditech, Welwyn
Garden City, UK), retinal nerve fibre layer thickness (GDx VCC, Zeiss,
Dublin, CA, USA). Threshold visual field analysis was done with the
Humphrey field analyser (Carl Zeiss Meditech), optic nerve head topog-
raphy determined using the HRT II (Heidelberg Retina Tomograph,
Heidelberg Engineering, Heidelberg, Germany), colour fundus photog-
raphy of optic disc and macula using a Topcon non-mydriatic retinal
camera TRC-NW6S and IMAGEnet Telemedicine System (Topcon
Corporation, Tokyo, Japan) with a 10- megapixel Nikon D80 camera
(Nikon Corporation, Tokyo, Japan).
Medication Confirmation of medication by nurse using repeat prescription slips
aNew measures in EPIC-Norfolk 3 (not applied at previous phases).
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suggests that exposure to a lifestyle associated with
greater near-work activity drives RE towards myopia
(of which the mechanistic outcome is longer axial
length), with individuals with higher education
having longer axial length.
Uncorrected refractive error (URE) in older
British adults23
Uncorrected refractive error (URE), although low in
the EPIC-Norfolk 3 cohort, was found to be associated
with age, reduced ownership of spectacles or
contact lenses for distance vision and in those who
self- reported poorer distance vision. Being able to
identify people with poor vision is important in plan-
ning provision of services to improve or correct vision.
Intraocular pressure (IOP) and corneal
biomechancs in older adults24
IOP is known as the main modifiable risk factor for
glaucoma, but IOP may be prone to measurement
error due to the biomechanical properties of other
components of the eye, in particular the cornea. We
Table 3 Range of function and health observed in the EPIC-Norfolk 3 cohort
Variables N Mean (SD) Median (IQR)
Men (N¼ 3861) Systolic blood pressure (mmHg) 3860 136.4 (15.4) 136.5 (126.5, 146.5)
Total cholesterol (mmol/l) 3604 5.0 (1.1) 4.9 (4.2, 5.7)
Body mass index (kg/m2) 3850 27.1 (3.6) 26.7 (24.7, 29.0)
Derived full MMSE score 3625 27.5 (1.4) 28.0 (27.0, 29.0)
Grip strength of strongest hand (kg) 3812 39.1 (8.3) 39.0 (33.5, 45.0)
Intraocular pressure (mm/Hg) 3753 16.2 (3.8) 15.6 (13.5, 18.4)
Smoking, % (N)
Current 4.2 (159)
Ex-Smoker 51.2 (1949)
Never Smoker 44.6 (1695)
Physical Activity, % (N)
Inactive 37.4 (1422)
Moderately-inactive 25.0 (954)
Moderately active 18.8 (713)
Active 18.8 (714)
Alcohol intake (units/week) 10.0 (2.0, 23.0)
Women (N¼ 4762) Systolic blood pressure (mmHg) 4758 135.9 (17.1) 136.0 (124.5, 146.5)
Total cholesterol (mmol/l) 4369 5.7 (1.1) 5.7 (5.0, 6.4)
Body mass index (kg/m2) 4753 26.6 (4.8) 25.9 (23.3, 29.0)
Derived full MMSE score 4333 27.5 (1.5) 28.0 (27.0, 29.0)
Grip strength of strongest hand kg) 4661 24.3 (5.6) 24.5 (21.0, 28.0)
Intraocular pressure (mm/Hg) 4640 16.3 (3.5) 16.1 (14.0, 18.4)
Smoking, % (N)
Current 4.5 (213)
Ex-Smoker 29.8 (1400)
Never Smoker 65.7 (3085)
Physical activity, % (N)
Inactive 37.2 (1748)
Moderately-inactive 32.2 (1513)
Moderately active 17.0 (796)
Active 13.6 (641)
Alcohol intake (units/week) 4.0 (0.0, 12.0)
SD, Standard Deviation; mmHg, millimetres of mercury; SF-MMSE, Short form MMSE Score; IOP, Intraocular pressure; IQR, Inter-
quartile Range
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attempted to obtain an accurate measure of IOP in
EPIC-Norfolk 3, accounting for the biomechanics of
the cornea. IOP was found to be higher in younger
people, women, those with higher systolic blood pres-
sure and those in sedentary occupation. We also
found the biomechanical characteristics of the
cornea, specifically the corneal resistance factor and
corneal hysteresis, declined with age and were higher
in women.
What are the main strengths and
weaknesses?
EPIC-Norfolk 3 provides objective measures of physi-
cal capability, cognitive function and visual health,
including retinal imaging, on a very well-character-
ized cohort. A major strength of the EPIC-Norfolk
study is the availability of longitudinal exposure and
health outcome data from baseline (1993–97) to the
present. From the 1HC onwards, emphasis has always
been placed on using validated instruments and
objective biomarkers to measure exposures including
diet and physical activity. In particular it provides the
opportunity to examine the trajectory of functioning
in the general population and in particular the deter-
minants of high as well as poor performance.
Most large cohort studies have to rely on linkage
with death records to obtain mortality by cause, and
on self- reported questionnaires for non-fatal health
outcomes which are limited by response rates and
subjective recall. The location of the cohort in a geo-
graphical region, Norfolk, means that follow-up
through hospital record and disease register linkage
and validation of medical records is facilitated,
enabling identification of major non-fatal health end-
points such as strokes, heart disease, diabetes, frac-
tures and arthritis in the whole cohort, in addition to
mortality and cancer by cause.
The main limitations of the study are those that
concern all cohort studies, in particular healthy volun-
teer bias and attrition. As one would expect, indivi-
duals would be less likely to participate in either the
baseline or subsequent follow-up examinations if they
were seriously ill, disabled or had major cognitive or
visual impairment.9 In EPIC-Norfolk 3, there was
likely to be selective truncation of individuals from
the cohort at the lower end of the distribution of
functional performance and some loss of frailer mem-
bers of the cohort, but there remains a large range of
performance and health to examine determinants of
healthy ageing. Furthermore, the availability of base-
line characteristics and mortality, and follow-up of
the original cohort, enable characterization of both
those who have and those who have not participated
in follow-up examinations.
Can I access of the data? Where
can I find out more?
EPIC-Norfolk has a wide range of collaborators.
Contact details, publications and the process for col-
laborating and data requests can be found on the
website (www.epic-norfolk.org.uk). Requests are
reviewed by the EPIC-Norfolk management commit-
tee and proposals should fulfil a number of criteria
including that the work is within the bounds of con-
sent given by participants. Scientific proposals must
be satisfactorily peer-reviewed and ethically reviewed
and approved.
Supplementary Data
Supplementary data are available at IJE online.
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KEY MESSAGES
 There are almost 20 years of longitudinal data on this well-characterized cohort of men and women
from Norfolk, first seen in 1993–97 when they were aged 40–79 years.
 EPIC-Norfolk 3, the third health examination of the cohort (2006–11), has shown that it is feasible to
include new objective measures of physical capability, cognitive function and visual health, making
EPIC-Norfolk well placed to investigate the determinants of health outcomes relevant to an ageing
population.
 This study has demonstrated that there is a wide range of heterogeneity in terms of health status,
function and capability in this community-dwelling ageing population. The information collected on
both environmental and genetic factors in this cohort will continue to contribute to the better under-
standing of the aetiology of a range of health outcomes, with a particular ability to investigate early
indicators of functional decline.
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